| Zacks Company Profile for Biolase, Inc. (BIOLQ : OTC) |
|
|
| |
| • Company Description |
| Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Number of Employees: 157 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $0.01 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 44,905 shares |
| Shares Outstanding: 36.60 (millions) |
| Market Capitalization: $0.39 (millions) |
| Beta: 0.03 |
| 52 Week High: $0.11 |
| 52 Week Low: $0.00 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
17.58% |
12.74% |
| 12 Week |
7.00% |
-6.24% |
| Year To Date |
-10.83% |
-15.78% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
John R. Beaver - President and Chief Executive Officer
Steven Sandor - Chief Operating Officer
Jennifer Bright - Chief Financial Officer
Jonathan T. Lord - Director
Jess Roper - Director
|
|
Peer Information
Biolase, Inc. (ITRJ)
Biolase, Inc. (BRLI.)
Biolase, Inc. (GOGY)
Biolase, Inc. (PSTX.)
Biolase, Inc. (ELGXQ)
Biolase, Inc. (CAH)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED/DENTAL-SUPP
Sector: Medical
CUSIP: 090911702
SIC: 3843
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/24
Next Expected EPS Date: 08/14/25
|
|
Share - Related Items
Shares Outstanding: 36.60
Most Recent Split Date: 7.00 (0.01:1)
Beta: 0.03
Market Capitalization: $0.39 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/14/25 |
|
|
|
| |
